Thursday, June 13, 2019

New drug to fight multi-drug resistant TB soon in Uttar Pradesh

The new anti-TB drug, with delamanid as active substance, is currently administered to patients primarily children in the age group of six to 17 years in a few southern states of India and is yet to be introduced in Uttar Pradesh, which reported 4.22 lakh patients in 2018.

from Zee News :Zee News - Health http://bit.ly/2MK62X7
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

India reports first known case of MYSM1-related bone marrow failure syndrome in child

Doctors have treated what is believed to be India’s first known case of MYSM1-related bone marrow failure syndrome, a very rare inherited d...